FDA says new rules should increase competition for insulin, but others aren't as sure - Modern Healthcare

FDA says new rules should increase competition for insulin, but others aren't as sure - Modern Healthcare: The Food and Drug Administration's new guidance should create a clear path for generic makers of insulin to enter the market. But some say it will do little to reverse its rising cost.